BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21168392)

  • 1. The N-terminal domain of human hemokinin-1 influences functional selectivity property for tachykinin receptor neurokinin-1.
    Mou L; Xing Y; Kong Z; Zhou Y; Chen Z; Wang R
    Biochem Pharmacol; 2011 Mar; 81(5):661-8. PubMed ID: 21168392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptor.
    Perrine SA; Beard DJ; Young JK; Simmons MA
    Eur J Pharmacol; 2008 Sep; 592(1-3):1-6. PubMed ID: 18634782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional selectivity of NK1 receptor signaling: peptide agonists can preferentially produce receptor activation or desensitization.
    Simmons MA
    J Pharmacol Exp Ther; 2006 Nov; 319(2):907-13. PubMed ID: 16916996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
    Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells.
    Koh YH; Tamizhselvi R; Bhatia M
    J Pharmacol Exp Ther; 2010 Mar; 332(3):940-8. PubMed ID: 20007404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
    El Zein N; Badran B; Sariban E
    Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tonic inhibitory role for cAMP in alpha(1a)-adrenergic receptor coupling to extracellular signal-regulated kinases 1/2.
    Jiao X; Gonzalez-Cabrera PJ; Xiao L; Bradley ME; Abel PW; Jeffries WB
    J Pharmacol Exp Ther; 2002 Oct; 303(1):247-56. PubMed ID: 12235258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
    Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hemokinin-1 promotes migration of melanoma cells and increases MMP-2 and MT1-MMP expression by activating tumor cell NK1 receptors.
    Zhang Y; Li X; Li J; Hu H; Miao X; Song X; Yang W; Zeng Q; Mou L; Wang R
    Peptides; 2016 Sep; 83():8-15. PubMed ID: 27458061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and proliferative effect of hemokinin-1 in human B-cells.
    Grassin-Delyle S; Buenestado A; Vallat L; Naline E; Marx S; Decocq J; Debré P; Bernard OA; Advenier C; Devillier P; Merle-Béral H
    Peptides; 2011 May; 32(5):1027-34. PubMed ID: 21334411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tachykinin receptor expression and function in human esophageal smooth muscle.
    Kovac JR; Chrones T; Preiksaitis HG; Sims SM
    J Pharmacol Exp Ther; 2006 Aug; 318(2):513-20. PubMed ID: 16714401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gq-mediated activation of c-Jun N-terminal kinase by the gastrin-releasing peptide-preferring bombesin receptor is inhibited upon costimulation of the Gs-coupled dopamine D1 receptor in COS-7 cells.
    Chan AS; Wong YH
    Mol Pharmacol; 2005 Nov; 68(5):1354-64. PubMed ID: 16061771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The signalling profile of recombinant human orexin-2 receptor.
    Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
    Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
    Cascieri MA; Huang RR; Fong TM; Cheung AH; Sadowski S; Ber E; Strader CD
    Mol Pharmacol; 1992 Jun; 41(6):1096-9. PubMed ID: 1377326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous expression and protein kinase A-dependent phosphorylation of the guanine nucleotide exchange factor Ras-GRF1 in human embryonic kidney 293 cells.
    Norum JH; Méthi T; Mattingly RR; Levy FO
    FEBS J; 2005 May; 272(9):2304-16. PubMed ID: 15853814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.
    Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E
    J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
    Vigna SR
    Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.